Angle Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Angle Biosciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C5326
◆発行会社(調査会社):GlobalData
◆発行日:2018年9月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Angle Biosciences Inc (Angle Biosciences), formerly Axela Inc, is a provider of optic technology solutions. The company offers Ziplex system, Flow-thru TipChips, panelPlus TipChips, diffractive optics technology, diffractive optics sensors, panelPlus sensors and software products. It offers technical and applications support, on-site and in-house training, extended warranty, service and maintenance contracts; and custom application development services. Angle Biosciences offers software for method creation, data gathering and data analysis. The company’s products are used in simplify multiplex biomarker detection for translational research and diagnostic testing. It markets its products in Canada, Ireland, Belgium, Luxemburg, Spain, the Netherlands, the UK and the US. Angle Biosciences is headquartered in Toronto, Ontario, Canada.

Angle Biosciences Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Angle Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Angle Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Angle Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Angle Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Angle Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 9
Angle Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Angle Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
PAML Enters into Co-Development Agreement with Axela 11
Axela Enters Into Technology Integration Agreement With Thermal Gradient 12
Isogen Life Science Enters Into Co-Marketing Agreement With Axela For Biomarker Analysis Platforms 13
Asset Transactions 14
ANGLE Acquires Assets from Axela 14
Acquisition 15
Axela Mulls Offering Itself For Sale 15
Angle Biosciences Inc – Key Competitors 16
Angle Biosciences Inc – Key Employees 17
Angle Biosciences Inc – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Angle Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts 2
Angle Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Angle Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Angle Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Angle Biosciences Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Angle Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 9
Angle Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
PAML Enters into Co-Development Agreement with Axela 11
Axela Enters Into Technology Integration Agreement With Thermal Gradient 12
Isogen Life Science Enters Into Co-Marketing Agreement With Axela For Biomarker Analysis Platforms 13
ANGLE Acquires Assets from Axela 14
Axela Mulls Offering Itself For Sale 15
Angle Biosciences Inc, Key Competitors 16
Angle Biosciences Inc, Key Employees 17

List of Figures
Angle Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Angle Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Angle Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Angle Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Angle Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Angle Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Angle Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Angle Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Angle Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Angle Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Rigel Pharmaceuticals, Inc.:企業の戦略・SWOT・財務分析
    Rigel Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Rigel Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Pharming Group NV (PHARM):製薬・医療:M&Aディール及び事業提携情報
    Summary Pharming Group NV (Pharming) is a specialty pharmaceutical company which develops nutritional products for the treatment of genetic diseases and unmet medical needs. The company’s flagship product, Ruconest (Rhucin in non-European territories) is a recombinant human C1 inhibitor approved for …
  • Virgin Islands Water and Power Authority:企業の戦略的SWOT分析
    Virgin Islands Water and Power Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • MIS Implants Technologies Ltd:医療機器:M&Aディール及び事業提携情報
    Summary MIS Implants Technologies Ltd (MIS) is a medical device company that offers advanced products and solutions for dental implantology treatment. The company offers products such as superstructures, dental implants, tools and kits, and solutions for oral restoration and health, among others. It …
  • Air Water Inc (4088):企業の財務・戦略的SWOT分析
    Air Water Inc (4088) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Sokolovska uhelna, pravni nastupce, A.S.:企業の戦略的SWOT分析
    Sokolovska uhelna, pravni nastupce, A.S. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Naked Wines plc (WINE):企業の財務・戦略的SWOT分析
    Naked Wines plc (WINE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Victorian WorkCover Authority:企業の戦略的SWOT分析
    Victorian WorkCover Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • ProAxsis Ltd:製品パイプライン分析
    Summary ProAxsis Ltd (ProAxsis), formerly ProAx-Sis Ltd, a subsidiary of NetScientific UK Ltd, is a developer of novel, point of care tests for the monitoring of patients with chronic diseases. The company develops proteasetags based point of care tests to offer a visual readout of active proteases …
  • Compass Minerals International Inc (CMP):企業の財務・戦略的SWOT分析
    Compass Minerals International Inc (CMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Nine Dragons Paper (Holdings) Limited:戦略・SWOT・企業財務分析
    Nine Dragons Paper (Holdings) Limited - Strategy, SWOT and Corporate Finance Report Summary Nine Dragons Paper (Holdings) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Taiwan Liposome Company Ltd (4152):製薬・医療:M&Aディール及び事業提携情報
    Summary Taiwan Liposome Company Ltd (TLC) is a clinical-stage pharmaceutical company that develops and commercializes novel nanomedicines based on drug delivery technology platform. The company’s pipeline products include TLC599, TLC590, TLC399 and TLC178. Its TLC 178 is used for the treatment of ad …
  • Statnett SF:電力:M&Aディール及び事業提携情報
    Summary Statnett SF (Statnett) transmits and distributes high voltage electricity in Norway primarily generated from its hydro-electric power plants. It operates as a system operator in the Norwegian energy system. The company is a state enterprise, established under the Act relating to state-owned …
  • Center for Applied Medical Research-製薬・医療分野:企業M&A・提携分析
    Summary Center for Applied Medical Research (CIMA), a subsidiary of University of Navarra is a medical research center that carries out research in the therapeutic areas of cardiovascular sciences, gene therapy and hepatology, oncology and neurosciences. The center also provides support services suc …
  • Steris Corp-医療機器分野:企業M&A・提携分析
    Summary Steris Corp (Steris), formerly Innovative Medical Technologies, a subsidiary of Steris Plc, is a medical device company that offers infection prevention and other procedural products and services. The company offers surgical equipment and image management, sterile processing equipment, surgi …
  • Novavax Inc (NVAX)-製薬・医療分野:企業M&A・提携分析
    Summary Novavax Inc (Novavax) is a clinical-stage biotechnology company that focuses on the discovery, development and commercialization of vaccines to prevent a range of infectious diseases. Its product portfolio includes recombinant nanoparticle vaccines and adjuvants. The company develops vaccine …
  • Tesla Motors, Inc.:企業の戦略・SWOT・財務情報
    Tesla Motors, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tesla Motors, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Raysearch Laboratories AB (RAY B):医療機器:M&Aディール及び事業提携情報
    Summary RaySearch Laboratories AB (RaySearch) is a medical technology company that develops software solutions for radiation therapy of cancer. The company provides software products such as rayplan, raystation and raycare. Its services include installation, support, training and training schedule. …
  • SunTrust Banks Inc:企業の戦略・SWOT・財務情報
    SunTrust Banks Inc - Strategy, SWOT and Corporate Finance Report Summary SunTrust Banks Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Abaxis Inc:医療機器:M&Aディール及び事業提携情報
    Summary Abaxis Inc (Abaxis) is a provider of technology, tools and services for wide range of medical applications for human and veterinary patient-care. The company focuses on development, manufacture, and marketing of portable blood analysis systems. Its portfolio encompasses patented products inc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆